Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	216.27	151.61	144.3	156.1	126.35	92.64
Short-Term Investments	59.94	70.04	112.51	19.66	10.32	12.98
Cash & Short-Term Investments	276.21	221.65	256.81	175.76	136.67	105.62
Cash Growth	10.27%	-13.69%	46.11%	28.60%	29.40%	23.73%
Accounts Receivable	146.81	136.29	114.94	88.8	78.8	66.01
Other Receivables	2.07	7.75	0.53	0.17	0.13	0.39
Receivables	148.87	144.04	115.47	88.98	78.93	66.39
Inventory	185.93	153.74	105.83	103.58	92.81	96.83
Prepaid Expenses	26.02	12.21	9.06	7.56	7.27	6.78
Restricted Cash	0.24	0.24	0.24	0.24	0.24	1.87
Other Current Assets	2.2	2.2	2.2	2.2	2.2	2.2
Total Current Assets	639.47	534.07	489.6	378.32	318.12	279.68
Property, Plant & Equipment	353.53	344.63	315.64	264.57	271.49	280.71
Long-Term Investments	-	11	15.21	2.41	3.99	-
Goodwill	3.4	3.05	3.22	3.13	3.31	3.94
Other Intangible Assets	568.83	587.61	610.08	34.17	35.56	36.68
Long-Term Deferred Tax Assets	71.12	71.12	53.25	38.53	22.4	24.98
Other Long-Term Assets	29.87	25.99	25.91	20.86	16.67	5.25
Total Assets	1,666	1,577	1,513	741.99	671.53	631.24
Accounts Payable	40.54	30.51	25.44	20.5	22.21	24.36
Accrued Expenses	96.25	111.57	54.75	46.19	44.17	45.95
Current Portion of Long-Term Debt	0.92	0.03	0.44	3.05	2.2	12.26
Current Portion of Leases	7.83	7.01	3.91	3	2.98	3.36
Current Income Taxes Payable	5.63	9.66	1.61	4.57	9.08	1.08
Other Current Liabilities	54.06	14.97	139.27	17.55	23.16	25.19
Total Current Liabilities	205.23	173.76	225.41	94.86	103.81	112.2
Long-Term Debt	608.28	601.41	588.96	72.84	74.38	33.58
Long-Term Leases	39.74	42.11	30.34	23.69	25.1	18.07
Pension & Post-Retirement Benefits	2.9	2.6	2.6	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.14	0.53	0.74
Other Long-Term Liabilities	33.33	25.3	26.18	21.79	22.18	17.92
Total Liabilities	889.48	845.17	873.49	213.33	226.01	182.51
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	527.22	505.4	486.06	455.08	422.42	410.06
Retained Earnings	642.45	568.79	409.27	271.72	180.34	117.77
Treasury Stock	-387.65	-332.71	-247.43	-189.52	-150.48	-121.81
Comprehensive Income & Other	-5.27	-9.18	-8.48	-8.62	-6.77	-3.72
Total Common Equity	776.75	732.3	639.42	528.66	445.52	402.31
Minority Interest	-	-	-	-	-	46.42
Shareholders' Equity	776.75	732.3	639.42	528.66	445.52	448.72
Total Liabilities & Equity	1,666	1,577	1,513	741.99	671.53	631.24
Total Debt	656.77	650.55	623.64	102.58	104.66	67.27
Net Cash (Debt)	-380.56	-428.9	-366.84	73.18	32.01	38.35
Net Cash Growth	-	-	-	128.62%	-16.53%	104.69%
Net Cash Per Share	-7.73	-8.24	-6.92	1.40	0.64	0.78
Filing Date Shares Outstanding	45.95	47.65	48.1	47.9	48.15	47.43
Total Common Shares Outstanding	46.35	47.62	48.07	48.11	47.71	47.5
Working Capital	434.24	360.31	264.19	283.46	214.31	167.48
Book Value Per Share	16.76	15.38	13.30	10.99	9.34	8.47
Tangible Book Value	204.51	141.64	26.13	491.36	406.65	361.69
Tangible Book Value Per Share	4.41	2.97	0.54	10.21	8.52	7.62
Land	7.56	7.42	7.48	7.45	7.62	7.72
Buildings	193.73	169.43	168.77	130.73	130.58	124.33
Machinery	335.62	313.38	291.43	237.74	235.26	238.15
Construction In Progress	24.04	36.69	18.68	50.84	41.19	43.98
Leasehold Improvements	46.04	42.01	41.69	31.54	29.22	30.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q